Novozymes A/S - Company Profile (OTCMKTS:NVZMY)

About Novozymes A/S - (OTCMKTS:NVZMY)

Novozymes A/S - logoNovozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: N/A
  • Sub-Industry: N/A
  • CUSIP: N/A
  • Web:
  • Market Cap: $13.29 billion
  • Outstanding Shares: 251,256,000
Average Prices:
  • 50 Day Moving Avg: $42.76
  • 200 Day Moving Avg: $38.24
  • 52 Week Range: $31.57 - $49.55
  • Trailing P/E Ratio: 29.89
  • Foreward P/E Ratio: 25.28
  • P/E Growth: 23.69
Sales & Book Value:
  • Annual Revenue: $2.09 billion
  • Price / Sales: 5.38
  • Book Value: $5.40 per share
  • Price / Book: 8.29
  • Annual Dividend: $0.33
  • Dividend Yield: 1.3%
  • EBIDTA: $735.1 million
  • Net Margins: 21.57%
  • Return on Equity: 27.48%
  • Return on Assets: 16.97%
  • Current Ratio: 1.79%
  • Quick Ratio: 1.10%
  • Average Volume: 21,297 shs.
  • Beta: 0.96

Frequently Asked Questions for Novozymes A/S - (OTCMKTS:NVZMY)

What is Novozymes A/S -'s stock symbol?

Novozymes A/S - trades on the OTCMKTS under the ticker symbol "NVZMY."

How were Novozymes A/S -'s earnings last quarter?

Novozymes A/S - (OTCMKTS:NVZMY) posted its quarterly earnings results on Thursday, August, 6th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by $0.02. Novozymes A/S - had a net margin of 21.57% and a return on equity of 27.48%. View Novozymes A/S -'s Earnings History.

Where is Novozymes A/S -'s stock going? Where will Novozymes A/S -'s stock price be in 2017?

4 analysts have issued twelve-month price objectives for Novozymes A/S -'s shares. Their predictions range from $47.50 to $47.50. On average, they expect Novozymes A/S -'s share price to reach $47.50 in the next year. View Analyst Ratings for Novozymes A/S -.

Who are some of Novozymes A/S -'s key competitors?

How do I buy Novozymes A/S - stock?

Shares of Novozymes A/S - can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Novozymes A/S - stock cost?

One share of Novozymes A/S - stock can currently be purchased for approximately $44.75.

Analyst Ratings

Consensus Ratings for Novozymes A/S - (OTCMKTS:NVZMY) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $47.50

Analysts' Ratings History for Novozymes A/S - (OTCMKTS:NVZMY)
DateFirmActionRatingPrice TargetDetails
5/10/2017Jefferies Group LLCReiterated RatingHold$47.50View Rating Details
2/10/2017JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details
1/5/2017Sanford C. BernsteinUpgradeMkt Perform -> OutperformView Rating Details
9/27/2016Berenberg BankInitiated CoverageSellView Rating Details
1/20/2016Goldman Sachs Group IncUpgradeSell -> NeutralView Rating Details
8/7/2015Nordea Equity ResearchDowngradeBuy -> HoldView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for Novozymes A/S - (OTCMKTS:NVZMY)
Earnings by Quarter for Novozymes A/S - (OTCMKTS:NVZMY)
Earnings History by Quarter for Novozymes A/S - (OTCMKTS:NVZMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/22/2015$0.36$0.36ViewN/AView Earnings Details
8/6/2015$0.35$0.33ViewN/AView Earnings Details
4/24/2015$0.33$0.33ViewN/AView Earnings Details
1/20/2015$0.23$0.30ViewN/AView Earnings Details
10/27/2014$0.35$0.34ViewN/AView Earnings Details
8/15/2014$0.38$0.34ViewN/AView Earnings Details
5/20/2014$0.33$0.40ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Novozymes A/S - (OTCMKTS:NVZMY)
Current Year EPS Consensus Estimate: $1.61 EPS
Next Year EPS Consensus Estimate: $1.77 EPS


Dividend History for Novozymes A/S - (OTCMKTS:NVZMY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Novozymes A/S - (OTCMKTS:NVZMY)
No insider trades for this company have been tracked by


Headline Trends for Novozymes A/S - (OTCMKTS:NVZMY)
Latest Headlines for Novozymes A/S - (OTCMKTS:NVZMY)
DateHeadline logoNovozymes A/S - (NVZMY) Stock Rating Reaffirmed by Jefferies Group LLC - May 10 at 2:48 PM logoNovozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017 - April 28 at 7:55 PM logoKMG Chemicals (KMG) Hits New 52-Week High on Solid Prospects - April 3 at 9:40 AM logoAre microbes the next revolution coming to Big Ag? - January 28 at 5:20 AM logo6:53 am Novozymes higher by 2% overseas following FY16 results - January 18 at 9:00 AM logoNovozymes upgraded by JP Morgan - December 9 at 6:53 PM logoConsumer Staples Delivered Top-Notch Performance for VGEAX - April 29 at 9:08 AM logoAn Above-Average Year for FHJUX - March 21 at 12:29 PM logoThe Fidelity Advisor Europe Fund: An Above-Average Year - February 22 at 7:03 PM logoKerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient Market - Seeking Alpha - January 30 at 1:44 PM logoHow the Fidelity Advisor Europe Fund Allocated Its Portfolio in 2015 - January 25 at 4:11 PM logoNovozymes upgraded by Goldman - January 20 at 8:22 AM logoNovozymes profit up; sees moderate growth in 2016 - MarketWatch - January 19 at 12:34 PM logoNovozymes profit up; sees moderate growth in 2016 - January 19 at 12:34 PM logoA Look at FHJUX’s Portfolio through November 2015 - December 23 at 5:00 PM logoThe Fidelity Advisor Europe Fund Class A (FHJUX): Historical Overview - October 28 at 2:02 PM logoThere is uncertainty around biofuels: Novzymes CEO - October 22 at 2:15 AM logoNovozyme earnings weaker than expected - August 6 at 2:15 AM logoEuropean Stocks Rise on Climb in German Investor Confidence - January 20 at 6:24 AM



Novozymes A/S - (NVZMY) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff